Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Forge Biologics, a member of the Ajinomoto Bio-Pharma Services group, announced it has achieved My Green Lab® Certification, the global gold standard for laboratory sustainability best practices, across all of its laboratories and manufacturing ...
read more
ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, will introduce LUMINATA™, an informatics system that enables organizations to establish effective impurity control strategies. ...
read more
Friday, September 21, 2018
Mylan announced the U.S. launch of Dalfampridine Extended-Release Tablets, 10 mg, the authorized generic version of Acorda's Ampyra.
read more
Quanticate, a leading global data-focused clinical research organization (CRO), has engineered a new Remote Source Data Verification (RSDV) Platform. The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical ...
read more
Wednesday, November 07, 2018
RxCelerate has hired Laura Hamilton as Executive Vice President, US Operations and opened an office in Cambridge, MA, just outside Boston.
read more
Monday, November 26, 2018
PerkinElmer announced its Vanadis NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Wednesday, April 25, 2012
ISPE announced today the Food and Drug Administration (FDA) will co-sponsor the upcoming “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md. USA on 4 – 5 June 2012. The conference is the first joint ISPE-FDA conference focused on CGMP issues.
read more
CDER Drug Safety Priorities 2018 is the FDA’s third annual report detailing key safety programs and activities, and highlighting the depth and versatility of drug safety initiatives across CDER and the FDA.
read more
Wednesday, September 30, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing (CDMO) company, has set a target of becoming the market leader in ADCs contract commercialization over the next five years.
read more
ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company's proprietary Leap-In Transposase genome engineering tools. ATUM has also begun construction of a new, 7,000 SF...
read more
Tuesday, December 16, 2025
CluePoints has won the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 Scrip Awards.
read more
Wednesday, September 21, 2022
WuXi Biologics announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
read more
Epizyme, Inc. has entered into two Cooperative Research and Development Agreements (CRADAs) with the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). The CRADAs will evaluate tazemetostat, Epizyme’s first-in-class EZH2...
read more
SGS announced that it has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. Its investment includes the installation of multiple analytical instruments, including an ...
read more